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The Spitz nevus was first described as the “mela-
noma of childhood” or “juvenile melanoma” by So-
phie Spitz in 1948 (1). Most spitzoid melanocytic 
proliferations can be classified as benign Spitz nevi 
or spitzoid melanomas based on published criteria 
(2-3). However, a subset of spitzoid lesions have his-
tological features that deviate from a typical Spitz 
nevus, yet are insufficient for a definitive diagnosis 
of spitzoid melanoma. The scope of spitzoid mela-
nocytic proliferations includes the typical Spitz ne-
vus, dysplastic Spitz nevus, Spitz nevus with atypia, 
melanoma evolving into a Spitz nevus, and spitzoid 
melanoma arising de novo (4). Lack of uniform cri-
teria for discrimination between malignant and be-
nign spitzoid melanocytic lesions makes it very dif-
ficult for pathologists and clinicians to interpret the 
histopathological findings and give an unequivocal 
diagnosis of melanoma. Using only histopathologi-
cal criteria, it is often very difficult to differentiate 
melanoma arising in a Spitz nevus from a Spitz ne-
vus with severe atypia. Thus, the term Spitz tumor 
of uncertain malignant potential (STUMP) is often 
used (5). Molecular methods have been employed 
recently to evaluate a spectrum of melanocytic le-
sions, including Spitz nevi. Molecular methods used 
for discrimination between malignant and benign 
spitzoid tumors include fluorescence in situ hybrid-
ization (FISH) and sequencing. The FISH method em-
ploys hybridization of specific fluorescent probes to 
gene regions and/or chromosomes. If there are more 
or less chromosome/gene copies than two per cell, it 
is regarded as an abnormality. Sequencing methods 
compare the genetic code of bioptic samples to the 
reference gene sequence found online and discrep-
ancies, mutations, insertions, or deletions of the ana-
lyzed gene are noted. While there have been some 
indications of a higher rate of chromosomal abnor-
malities and pathogenic mutations in spitzoid mela-
noma, no consensus has been reached (6,7). These 
new tools have provided further insight into these 
controversial lesions and can aid in their evaluation 
and further clinical approach. 
Figure 1. A 7-year-old boy with a brown pigmented skin nodule at the ala of nose near the naso 
labial fold, before (A) and after (B) re-excision. 
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A 7-year-old boy presented with a brown nodule 
on the nose (Figure 1, A). The mother noticed that the 
lesion had been traumatized a few days prior to exam-
ination, with minor bleeding. Family history was neg-
ative for skin cancer. Examination showed a smooth 
brown papule 5 mm in diameter. On dermatoscopy, 
the pigment was uniform and symmetric with a sign 
of the trauma in the center of the lesion. Findings 
for the remainder of the physical examination were 
normal. Photoprotection and possible preventive ex-
cision was suggested. However, on second examina-
tion the mother noted a recurring trauma to the area 
of the nose, after which excision was suggested. A full 
excision was performed, and histological examina-
tion demonstrated a well demarcated, symmetrical, 
compound proliferation of large Spitzoid melano-
cytes (Figure 2). Cells were predominantly arranged 
in nests, while the intradermal component displayed 
peri- and inter-adnexal growth patterns. Matura-
tion with descent was apparent in a larger part of 
the lesion. Centrally, however, in the deep levels of 
the tumor, several large nests of strikingly enlarged 
melanocytes with a high nuclear-to-cytoplasmic ra-
tio were found, with a lack of maturation (Figure 2, 
A). Kamino bodies could not be seen. Mitotic figures 
were noted in both the superficial and deep levels of 
the tumor, and there were 2 mitosis per mm2 (Figure 
2, B and C). Human melanoma black-45 (HMB-45) ex-
pression was strongly positive at the junctional com-
ponent and decreasing toward the base of the lesions 
(Figure 2, D). Taken together, these findings were con-
cerning but not diagnostically decisive with regard to 
malignancy, as determined by two dermatopatholo-
gists. The diagnosis of an atypical Spitz tumor was 
made and upon consultation updated to a high-risk 
atypical Spitz tumor (Spitz nevus of uncertain malig-
nant potential). A thoracic X-ray and ultrasound of 
the neck and abdomen were performed, revealing 
reactive lymph nodes of hypoechoic structure and a 
Figure3. Sequencing electropherograms, with posi-
tions of possible mutations indicated with arrows: (A) 
BRAF exon 15 V600E wild-type; (B) NRAS exon 2 G12V 
wild-type; (C) NRAS exon 3 Q61K wild-type.
Figure2. Atypical Spitz tumor stained with Hemalaun-
eosin and immunohistochemically for human mela-
noma black-45 (HMB-45). (A) Nests near the base of 
the lesion harboring large, pleomorphic cells without 
signs of maturation and high nuclear-to-cytoplasmic 
ratios (H&E, magnification ×400). (B) Three apparent 
mitoses are indicated with arrows (H&E, magnifica-
tion ×200). (C) Mitosis near the deep margin of the 
lesion is indicated with an arrow (H&E, magnification 
×100). (D) HMB-45 immunostaining in the upper part 
of the lesion (magnification ×100).
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slightly enlarged liver with a normal echogenic struc-
ture. No focal lesions were observed.
A consulting dermatopathologist thought that 
although some features were reminiscent of a Spitz 
nevus, other characteristics were worrisome and in-
dicated melanoma, so molecular analysis was recom-
mended. Sequencing of NRAS and BRAF genes on 
DNA isolated from cells suspected to have malignant 
potential was performed. A pathologist selected the 
area which contained 70% of atypical cells, which 
were sampled by manual microdissection. The poly-
merase chain reactions (PCR) and sequencing reac-
tions were performed using primers and annealing 
temperatures according to van Dijk et al. (7). Both 
NRAS (exon 2 and 3) and BRAF genes were wild-types 
(Figure 3). A reduced re-excision using a Thiersch free 
skin graft was performed (Figure 1, B).
Written informed consent was obtained from the 
patient for publication of this case report and any ac-
companying images. The study was approved by the 
institutional ethics committee clearance.
Evaluating the malignant potential and assessing 
the risk of aggressive behavior of atypical Spitz tu-
mors is one of the biggest challenges in modern skin 
pathology. Only a few studies with sufficient num-
bers of cases and long-term follow-up are available, 
and there are still many uncertainties regarding the 
nature of the disease. Recent finding by Hung et al. 
that the sentinel node metastasis is not predictive for 
poor outcome in patient with spitzoid melanocytic 
tumors only narrows down the possibilities of risk 
assessment and survival prediction using classical 
pathohistological methods (8). 
Tom et al. suggested an algorithm for the evalua-
tion of pediatric STUMP lesions (5). It includes com-
parative genomic hybridization (CGH) and several 
specific fluorescence in situ (FISH) probes to check 
for genetic instability (5). However, CHG is time con-
suming, expensive, and less reliable for lesions with 
only a subset of atypical cells, i.e. spitzoid melano-
mas evolving from a Spitz nevus. Furthermore, FISH 
probes failed to detect several malignant spitzoid le-
sions according to Raskin et al. (6). The study by van 
Dijk et al. (7) concluded that NRAS and BRAF sequenc-
ing in STUMP lesions is the most promising tool for 
evaluation of Spitz nevi with low percentage of cells 
suspected to have malignant potential. For that rea-
son, we decided to perform NRAS and BRAF gene se-
quencing on DNA of isolated tumor cells.  
The excision of sentinel lymph nodes could have a 
negative impact on the immunological system of chil-
dren, so there is a need for development and further 
consideration of less invasive methods for evaluation 
of STUMP lesions. The other widely accepted evalua-
tion method for high-risk atypical Spitz nevi is wide 
re-excision. In our case, a 5 mm lesion on the nose 
and additional 1 cm wide re-excision would leave a 
scar which could have serious psychological implica-
tions for the child. Considering that, and due to nega-
tive molecular analysis along with other character-
istics of the tumor, we decided to perform reduced 
re-excision of the lesion. Close clinical follow-up was 
done every 6 months for the next 28 months, finding 
no recurrent Spitz’s nevi or detectable focal lesions. 
Follow-up included ultrasound of the axillary region, 
neck, abdomen and the inguinal region as well as 
dermatoscopy of the nasal region. We believe that 
newer techniques may provide information that can 
be helpful in evaluating the possible malignant po-
tential of the lesion and in deciding further therapeu-
tic approach. However, there is no easy way for man-
aging such an ambiguous disease; every case needs 
to be carefully analyzed and all the decisions need to 
be made carefully, weighing possible advantages and 
disadvantages for the patient, including the fact that 
children are not simply “small adults” and that each 
localization requires distinct access.
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